Theralase Technologies Inc. V.TLT

The longer big pharma waits the greater the chance they wili

[Galaxym31]

miss out .Their shareholders will punish them for such poor vision .

[CancerSlayer]

Agree, but a BTD would help change that dynamic...there would be just too much to ignore (& too much to gain) with that degree of derisking, especially considering the oncology field generally has the highest BTD approval percentage.  Per a report from Pink Sheet 16 April 2021, two-thirds of Breakthrough Therapy Deignations resulted in successful FDA approvals. The BTD truly represents a

[CancerSlayer]

Clarification:   Two-thirds of BTDs "in the oncology space" resulted in FDA approvals...when considering the other top fields combined, the percentage is around 40% (per Pink Sheet 16 April 2021).

[Galaxym31]

They big pharma  dont need anything other than an ability to read to see the future at least put a couple  of hundred million into it and get a first refusal . Keytruda 1.25 billion per year , horrible side effects .

[CancerSlayer]

To be honest, though an acquisition by or JV with Big Pharma may be nice to my pocketbook, I'd ultimately like to see a partnership with a smaller-sized player/Pharma that could provide a more balanced emphasis & less of a laser focus on the bottom line.  Big Pharma's business strategy & incentives historically trump the needs for innovative research & the needs of the

[Alamir1111]

Do you have some idea who those smaller size bio s would be?

[CancerSlayer]

I see potential opportunities, but don't want to jinx a potentially good thing ; ) I'm hopeful the company has/is doing their DD. JMO...

[Galaxym31]

I lean towards big pharma to run hard with it , huge money , many cancers low side effects .

[CancerSlayer]

Big pharma would be an ideal financial dream come true...But I see an alternative route (possibly more realistic) that includes partnering with a forward-looking small to mid-cap company (pre or post BTD) that can help fund us to an FDA approval & help fund additional Phase 1 studies.  In the ideal scenario, we then move to the Nasdaq & Big Pharma starts to take a much more serious

[Oilminerdeluxe]

It sounds so easy. That Lbiati hiring should be able to make a deal with all the recent releases one would think. If not, let her go. Fingers crossed for a solid financing and a bright future. To BTD or not BTD,

[plantrader]

Oilminer, on the Lbiati subject. I wonder if part of the difficulty could be that area being told something similar by everyone such as some bother us until you at least have BTD? Or something similar to that? Because we already see that that's what the stock appears to be saying, don't we? Maybe it's just not de-risked enough for the real players. But if it's all legit, then one

[Oilminerdeluxe]

Yep, it's tricky. I have no expections of 10m. If it happens great. If not, well, if they can get enough to last the year, then perhaps we actually will get BTD before the coffers are empty.